316140:KRXWoori Financial Group, Inc. Analysis
Data as of 2026-05-29 - not real-time
₩29,700.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Woori Financial Group is trading at 29,700 KRW, comfortably above the 29,200 KRW support level but below its 38,944 KRW DCF fair value, indicating a sizable upside potential. The stock sits near its 20‑day SMA (31,582 KRW) and below the 50‑day SMA (32,835 KRW), while the 200‑day SMA (29,264 KRW) provides a long‑term anchor. Technical momentum is mixed: the RSI of 34 suggests the market is approaching oversold territory, yet the MACD histogram remains negative, signaling lingering bearish pressure. Volatility is elevated at roughly 27 % over the past 30 days, but the beta of 0.58 points to lower systematic risk compared to the broader market, and the Fear & Greed Index is in "Extreme Greed" territory, reflecting strong investor appetite.
Fundamentally, the company trades at a forward P/E of 6.1 versus an industry average of 16.7, underscoring a clear valuation discount. A dividend yield of 4.59 % with a payout ratio around 34 % appears sustainable given robust operating cash flow and a solid capital base. Recent earnings reports highlighted steady net income, robust non‑interest income growth, and an analyst upgrade from Hold to Buy, reinforcing confidence in the firm's earnings trajectory. Combined with a projected upside of over 40 % relative to current pricing, the fundamentals and market sentiment together suggest the stock is undervalued and positioned for a recovery.
Fundamentally, the company trades at a forward P/E of 6.1 versus an industry average of 16.7, underscoring a clear valuation discount. A dividend yield of 4.59 % with a payout ratio around 34 % appears sustainable given robust operating cash flow and a solid capital base. Recent earnings reports highlighted steady net income, robust non‑interest income growth, and an analyst upgrade from Hold to Buy, reinforcing confidence in the firm's earnings trajectory. Combined with a projected upside of over 40 % relative to current pricing, the fundamentals and market sentiment together suggest the stock is undervalued and positioned for a recovery.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating short‑term downside pressure
- Proximity to support level at 29,200 KRW
- Analyst upgrade to Buy supporting near‑term confidence
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Revenue growth of ~6 % and strong non‑interest income
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Low beta and moderate volatility suggest defensive profile
- Long‑term upside potential exceeding 40 % based on fair‑value model
- Consistent dividend payments enhancing total return
Key Metrics & Analysis
Financial Health
Revenue Growth5.90%
Profit Margin30.79%
P/E Ratio6.1
ROE8.52%
ROA0.56%
Op. Cash Flow₩5718.0B
Industry P/E16.7
Technical Analysis
TrendNeutral
RSI34.1
Support₩29,200.00
Resistance₩33,950.00
MA 20₩31,582.50
MA 50₩32,835.00
MA 200₩29,264.00
MACDBearish
VolumeDecreasing
Fear & Greed Index93.93
Valuation
Fair Value₩38,944.70
Target Price₩41,710.53
Upside/Downside40.44%
GradeUndervalued
TypeValue
Dividend Yield4.59%
Risk Assessment
Beta0.58
Volatility27.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.